- Headquarters
- San Francisco, California
- Founded
- 2015
- Business Model
- B2B
- Website
- boltbio.com
- Total Funding
- $93.5M
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Bolt Biotherapeutics is a clinical-stage biotech company working to harness the power of the immune system to improve lives and eradicate cancer. The company develops novel immunotherapies that use foreign patterns to trigger the innate immune system, teaching it to recognize and kill cancer. Founded in 2015 by Stanford's Dr. Edgar G. Engleman to expand his pioneering work in cancer immunotherapeutics and myeloid biology, Bolt applies that expertise to treatments for patients with unmet cancer needs.
Summary
Bolt Biotherapeutics is a Biotech company based in San Francisco, United States, founded in 2015. It has raised $93.5M in total across 1 round.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Feb 2021
Sign up to see all 2 events
Funding, valuations, and company events, with amounts and investors where available.
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bolt-biotherapeutics"><img src="https://indexed.vc/api/badge/company/bolt-biotherapeutics" alt="Bolt Biotherapeutics on Indexed.vc" width="260" height="76" /></a>